Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial

医学 内科学 安慰剂 质子抑制剂泵 临床终点 人口 不利影响 双盲 安慰剂对照研究 胃肠病学 随机对照试验 环境卫生 病理 替代医学
作者
Lucas I. Wauters,Helena Slaets,Kim De Paepe,Matthias Ceulemans,Suzan Wetzels,Karlien Geboers,Joran G. Tóth,Wannes Thys,Raf Dybajlo,Daan Walgraeve,Erik A.L. Biessen,Kristin Verbeke,Jan F. Tack,Tom Van de Wiele,Niels Hellings,Tim Vanuytsel
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:6 (10): 784-792 被引量:107
标识
DOI:10.1016/s2468-1253(21)00226-0
摘要

Current treatments for functional dyspepsia have limited efficacy or present safety issues. We aimed to assess spore-forming probiotics in functional dyspepsia as monotherapy or add-on therapy to long-term treatment with proton-pump inhibitors.In this single-centre, randomised, double-blind, placebo-controlled pilot trial that took place at University Hospitals Leuven (Leuven, Belgium), adult patients (≥18 years) with functional dyspepsia (as defined by Rome IV criteria, on proton-pump inhibitors or off proton-pump inhibitors) were randomly assigned (1:1) via computer-generated blocked lists, stratified by proton-pump inhibitor status, to receive 8 weeks of treatment with probiotics (Bacillus coagulans MY01 and Bacillus subtilis MY02, 2·5 × 109 colony-forming units per capsule) or placebo consumed twice per day, followed by an open-label extension phase of 8 weeks. Individuals with a history of abdominal surgery, diabetes, coeliac or inflammatory bowel disease, active psychiatric conditions, and use of immunosuppressant drugs, antibiotics, or probiotics in the past 3 months were excluded. All patients and on-site study personnel were masked to treatment allocation in the first 8 weeks. Symptoms, immune activation, and faecal microbiota were assessed and recorded. The primary endpoint was a decrease of at least 0·7 in the postprandial distress syndrome (PDS) score of the Leuven Postprandial Distress Scale in patients with a baseline PDS score of 1 or greater (at least mild symptoms), assessed in the intention-to-treat population. This study is registered with ClinicalTrials.gov, NCT04030780.Between June 3, 2019, and March 11, 2020, of 93 individuals assessed for eligibility, we included 68 patients with functional dyspepsia (51 [75%] women, mean age 40·1 years [SD 14·4], 34 [50%] on proton-pump inhibitors). We randomly assigned 32 participants to probiotics and 36 to placebo. The proportion of clinical responders was higher with probiotics (12 [48%] of 25) than placebo (six [20%] of 30; relative risk 1·95 [95% CI 1·07-4·11]; p=0·028). The number of patients with adverse events was similar with probiotics (five [16%] of 32) and placebo (12 [33%] of 36). Two serious adverse events occurring during the open-label phase (appendicitis and syncope in two separate patients) were assessed as unlikely to be related to the study product.In this exploratory study, B coagulans MY01 and B subtilis MY02 were efficacious and safe in the treatment of functional dyspepsia. Participants had potentially beneficial immune and microbial changes, which could provide insights into possible underlying mechanisms as future predictors or treatment targets.MY HEALTH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温暖马里奥完成签到,获得积分10
刚刚
1秒前
suyi发布了新的文献求助10
1秒前
2秒前
2秒前
chencc完成签到,获得积分10
2秒前
Nn完成签到,获得积分10
3秒前
哈哈发布了新的文献求助10
3秒前
852的应助被盼夏采纳,获得10
3秒前
南洲完成签到,获得积分20
4秒前
852的应助被leo采纳,获得10
4秒前
liuuucz发布了新的文献求助10
4秒前
科研通AI2S的应助被XZZ采纳,获得10
4秒前
5秒前
5秒前
5秒前
冠诚完成签到,获得积分10
5秒前
思源的应助被hhy采纳,获得10
5秒前
淡淡菲鹰完成签到,获得积分10
5秒前
6秒前
6秒前
王新华发布了新的文献求助10
7秒前
8秒前
wcb发布了新的文献求助10
8秒前
隐形曼青的应助被Lee采纳,获得10
9秒前
yun发布了新的文献求助10
9秒前
10秒前
Hus11221完成签到,获得积分10
10秒前
锅锅发布了新的文献求助10
10秒前
11秒前
涵泽发布了新的文献求助10
11秒前
张倩发布了新的文献求助10
11秒前
彭于晏的应助被哈哈采纳,获得10
11秒前
汉堡包的应助被柔弱的冰兰采纳,获得10
11秒前
旭日发布了新的文献求助50
12秒前
秃头小宝贝完成签到,获得积分10
13秒前
陶醉的元槐完成签到,获得积分10
13秒前
天天开心发布了新的文献求助10
14秒前
fabian完成签到,获得积分10
14秒前
秋风的应助被完美的紊采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172071
求助须知:如何正确求助?哪些是违规求助? 9564815
关于积分的说明 21776551
捐赠科研通 7763646
什么是DOI,文献DOI怎么找? 3431120
关于科研通互助平台的介绍 2554977
邀请新用户注册赠送积分活动 2476153